TESS MCKINNEY: Open Payments
NPI 1922687821 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$474 in 21 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $474
Food & beverage: $474
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $123 |
| Astellas Pharma US Inc | 4 | $110 |
| ABBVIE INC. | 4 | $76 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| Biogen, Inc. | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Antares Pharma, Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| PFIZER INC. | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $18 |
Products named: Veozah, Ozempic, VRAYLAR, CAPLYTA, SKYCLARYS, GVOKE HYPOPEN, Rybelsus, XYOSTED.
Industry payments across TN — which companies pay providers there.
